Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,544 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03421782 | Fatigue Interventions in Cancer (Exercise Intervention) | completed | Phase 2 | 126 | University of UtahOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT06661902 | Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial(BURN) | completed | Phase 1 / Phase 2 | 350 | University of WashingtonOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07413120 | Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery | completed | Phase 3 | 40 | Incheon St.Mary's HospitalOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT01543659 | Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | 77 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT02274779 | Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer(OLIGOPELVIS) | completed | Phase 2 | 74 | Institut Cancerologie de l'OuestOTHER | 1 | Feb 13, 2026 | clinicaltrials |
| NCT02313623 | MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research | completed | — | 600 | Yale UniversityOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT03995888 | Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer | completed | Phase 1 | 24 | Blue Earth DiagnosticsINDUSTRY | 1 | Feb 12, 2026 | clinicaltrials |
| NCT04662996 | Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAs(MiR_CPMRC) | completed | N/A | 33 | University Hospital, ToursOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT01517451 | Radiation and Androgen Ablation for Prostate Cancer | completed | Phase 1 / Phase 2 | 45 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT06253065 | Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate Cancer | completed | — | 225 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 11, 2026 | clinicaltrials |
| NCT00893035 | Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients | completed | — | 885 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT03707574 | Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study | completed | — | 64 | National Cancer Institute (NCI)NIH | 2 | Feb 4, 2026 | clinicaltrials |
| NCT04484246 | Sarcopenia in Older Patient With Prostate Cancer, Prevalence and Incidence After Androgen Deprivation Therapy(HoSAGE) | completed | — | 112 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06379880 | Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution(FEGALA) | completed | N/A | 411 | Centre Paul StraussOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06764992 | Exploring Men s Prostate Cancer Genetic Risk Perceptions | completed | — | 100 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT03535831 | PSMA PET Registry (18F-DCFPyL)(PM-PPR) | completed | N/A | 142 | University Health Network, TorontoOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT05701007 | Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland | completed | — | 1,083 | PfizerINDUSTRY | 1 | Jan 29, 2026 | clinicaltrials |
| NCT02003924 | Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer(PROSPER) | completed | Phase 3 | 1,401 | PfizerINDUSTRY | 32 | Jan 27, 2026 | clinicaltrials |
| NCT03338790 | An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer(CheckMate 9KD) | completed | Phase 2 | 292 | Bristol-Myers SquibbINDUSTRY | 11 | Jan 27, 2026 | clinicaltrials |
| NCT05011799 | The Peer Genetic Study | completed | N/A | 149 | Thomas Jefferson UniversityOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT03565835 | Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer | completed | Phase 2 | 31 | Montefiore Medical CenterOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT04782713 | Smart Prostate Specific Antigen (PSA) Screening Study | completed | N/A | 49 | University of Illinois at ChicagoOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT03503344 | Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer(PILLAR) | completed | Phase 2 | 26 | University of California, San FranciscoOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT05470036 | Improving Germline Testing in At-Risk Patients With Prostate Cancer(IMPRINT) | completed | N/A | 50 | University of California, San DiegoOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT03556904 | FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE) | completed | Phase 2 | 14 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT04763824 | KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice(KANSURVIVE) | completed | N/A | 15 | University of Kansas Medical CenterOTHER | 1 | Jan 14, 2026 | clinicaltrials |
| NCT00186368 | Microarray Analysis of Gene Expression in Prostate Tissues | completed | — | 867 | Stanford UniversityOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT07333807 | Efficacy of the Pelvic Clock® Device for Functional Recovery After Robotic-Assisted Radical Prostatectomy | completed | N/A | 60 | Tri-Service General Hospital (TSGH)OTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT04870515 | Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study | completed | N/A | 20 | Fred Hutchinson Cancer CenterOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT05041504 | A Web-based Peer Navigation Program for Men With Prostate Cancer | completed | N/A | 184 | University Health Network, TorontoOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT07331246 | TENS for Pain Relief During Fusion-Guided Prostate Biopsy | completed | N/A | 84 | Medical University of GdanskOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT03996005 | MRI- Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer(MRI-TULSAP) | completed | N/A | 25 | University Hospital, Strasbourg, FranceOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT02189486 | Prostate Cancer Upgrading Reference Set | completed | — | 382 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT04717154 | Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer(INSPIRE) | completed | Phase 2 | 69 | Radboud University Medical CenterOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT06840535 | A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer(OncoACP-3) | completed | Phase 1 | 20 | Philogen S.p.A.INDUSTRY | 1 | Jan 6, 2026 | clinicaltrials |
| NCT03734757 | Interest of Trimodality PET-CT Choline MRI Before Radiotherapy in High Risk Prostate Cancer(DEMETER) | completed | N/A | 20 | Centre Henri BecquerelOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT06016725 | Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial(E-PROOF) | completed | N/A | 75 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT01809691 | S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer(S1216) | completed | Phase 3 | 1,313 | SWOG Cancer Research NetworkNETWORK | 1 | Dec 31, 2025 | clinicaltrials |
| NCT06072196 | A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC) | completed | — | 3,017 | PfizerINDUSTRY | 1 | Dec 31, 2025 | clinicaltrials |
| NCT01823549 | Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients | completed | — | 109 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT03869216 | Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men | completed | N/A | 161 | Xavier University of Louisiana.OTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT02657863 | Cancer DNA Detection in Blood and Urine | completed | — | 61 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT04081636 | Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications(ProBE-PC) | completed | N/A | 840 | Albany Medical CollegeOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT06783088 | Quantification With Lutetium-177 on Cadmium-Zinc-Telluride Camera 3D(QUADO) | completed | — | 20 | Central Hospital, Nancy, FranceOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT02854436 | An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies(Galahad) | completed | Phase 2 | 289 | Janssen Research & Development, LLCINDUSTRY | 15 | Dec 22, 2025 | clinicaltrials |
| NCT02985957 | A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650)(CheckMate 650) | completed | Phase 2 | 351 | Bristol-Myers SquibbINDUSTRY | 10 | Dec 22, 2025 | clinicaltrials |
| NCT04428788 | Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 131 | CelgeneINDUSTRY | 1 | Dec 22, 2025 | clinicaltrials |
| NCT06055946 | Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatectomy(BARVANA LONG) | completed | — | 70 | Aesculap AGINDUSTRY | 1 | Dec 22, 2025 | clinicaltrials |
| NCT02485379 | Assessment of Prostate MRI Before Prostate Biopsies(MRI-FIRST01) | completed | N/A | 275 | Hospices Civils de LyonOTHER | 1 | Dec 19, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Feb 17, 2026source: clinicaltrials